Two recent articles – one in the Washington Post and one in the Wall Street Journal – have raised the spectre of how smartphone medical apps imply an imminent trainwreck between today’s rapid-pace innovation and last century’s slower-going FDA regulation … Continue reading at ComplianceZen.com →
From the Blog
FDA Training Records – 3 Risky Challenges
Should FDA Regulate Medical Apps?
3D Printing and Nanobots – FDA Challenges
From the Pharma Contracting & Outsourcing Conference
Medical Apps and FDA Regulation
Client Success Stories
“We commissioned Cerulean's services to develop our knowledge and internal expertise. John Avellanet delivered against this objective and then some. John kept our objectives front of mind in every conversation and deliverable he made. He also considered our objectives as a baseline, consistently delivering more than was documented and expected.”
- Gordon Russell, President, & Simon Elleway, Director, Dedham, Massachusetts
